Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 9703914, 2 pages

RNA Vaccination Therapy: Advances in an Emerging Field

1TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, 55131 Mainz, Germany
2Department of Dermatology, University Hospital of Zurich, 8091 Zurich, Switzerland
3Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
4Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
5Laboratory of Molecular and Cellular Therapy (LMCT), Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium
6Avidity NanoMedicines, La Jolla, CA 92037, USA

Received 27 January 2016; Accepted 28 January 2016

Copyright © 2016 Sebastian Kreiter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Conner C. Earl, Mark T. Smith, Richard A. Lease, and Bradley C. Bundy, “Polyvinylsulfonic acid: A Low-cost RNase inhibitor for enhanced RNA preservation and cell-free protein translation,” Bioengineered, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Patrick Gladfelter, Noureldien H.E. Darwish, and Shaker A. Mousa, “Current status and future direction in the management of malignant melanoma,” Melanoma Research, vol. 27, no. 5, pp. 403–410, 2017. View at Publisher · View at Google Scholar
  • Yi Liu, Zhen Hua Chia, Johannes Nathaniel Min Hui Liew, Shi Min Or, and Kyle K.L. Phua, “Modulation of mRNA Translation and Cell Viability by Influenza A Virus Derived Nonstructural Protein 1,” Nucleic Acid Therapeutics, 2018. View at Publisher · View at Google Scholar